Clinical trial
Prediction of 30-Day Readmission Using Machine Learning
NCT04849312
Study timeline
Study start (actual)2017-06-01Date precision: day
Registry last updated2026-03-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Infectionunresolved
Heart Failureunresolved
Chronic Obstructive Pulmonary Diseaseunresolved
Asthmaunresolved
Gout Flareunresolved
Chronic Kidney Diseasesunresolved
Hypertensive Urgencyunresolved
Atrial Fibrillation Rapidunresolved
Anticoagulants; Increasedunresolved
Interventions
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
Biofourmis Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04849312 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.